Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: Different effects on cytokines and apoptosis
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 119 (2), 146-155
- https://doi.org/10.1016/j.clim.2006.01.007
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- B cell apoptosis accelerates the onset of murine lupusEuropean Journal of Immunology, 2003
- Cytokines and systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2000
- Treatment of Lupus in NZB/W F1 Mice with Monoclonal Antibody Against Fas LigandJournal of Autoimmunity, 2000
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.Journal of Clinical Investigation, 1998
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.The Journal of Experimental Medicine, 1994
- Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosusEuropean Journal of Immunology, 1993
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Administration of prednisolone in vivo affects the ratio of and the LDH-isoenzyme pattern of human T lymphocytesClinical Immunology and Immunopathology, 1984